CN103601666B - The preparation method of octahydro pentamethylene [C] pyrroles - Google Patents

The preparation method of octahydro pentamethylene [C] pyrroles Download PDF

Info

Publication number
CN103601666B
CN103601666B CN201310627653.8A CN201310627653A CN103601666B CN 103601666 B CN103601666 B CN 103601666B CN 201310627653 A CN201310627653 A CN 201310627653A CN 103601666 B CN103601666 B CN 103601666B
Authority
CN
China
Prior art keywords
preparation technology
tetrahydrofuran
reaction substrate
pyrroles
reductive agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310627653.8A
Other languages
Chinese (zh)
Other versions
CN103601666A (en
Inventor
赵长阔
李晓飞
王先恒
王兴华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zunyi Medical University
Original Assignee
Zunyi Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zunyi Medical University filed Critical Zunyi Medical University
Priority to CN201310627653.8A priority Critical patent/CN103601666B/en
Publication of CN103601666A publication Critical patent/CN103601666A/en
Application granted granted Critical
Publication of CN103601666B publication Critical patent/CN103601666B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention provides a kind of preparation method of octahydro pentamethylene [C] pyrroles (I); The method, by under Lewis acid promotion, obtains octahydro pentamethylene [C] pyrroles (I) by boron reductive agent reduction ring valeryl group with imine moiety (II) single stage method.

Description

八氢环戊烷[C]吡咯的制备方法The preparation method of octahydrocyclopentane [C] pyrrole

技术领域technical field

本发明属于化学制药领域,具体地涉及药物关键合成中间体八氢环戊烷[C]吡咯(octahydrocyclopenta[c]pyrrole,CAS No.为5661-03-0)的制备方法。The invention belongs to the field of chemical pharmacy, and in particular relates to a preparation method of octahydrocyclopenta[c]pyrrole (octahydrocyclopenta[c]pyrrole, CAS No. 5661-03-0), a key synthetic intermediate of medicine.

背景技术Background technique

丙型肝炎病毒是一种单股线性正链RNA病毒,由于会导致各种慢性肝病发生,丙型肝炎病毒是迄今为止人类因疾病而死亡的主要杀手之一。2011年美国食品药品管理局(FDA)批准了特拉匹韦(Telaprevir)和伯赛匹韦(Boceprevir)两个小分子药物在美国上市。这两个蛋白酶抑制剂的上市,改变了以往十多年来丙肝的治疗效果;这在丙肝治疗领域是比较大的突破。Hepatitis C virus is a single-stranded linear positive-sense RNA virus. Because it can cause various chronic liver diseases, HCV is one of the main killers of human deaths due to diseases so far. In 2011, the U.S. Food and Drug Administration (FDA) approved two small-molecule drugs, Telaprevir and Boceprevir, to be marketed in the United States. The launch of these two protease inhibitors has changed the treatment effect of hepatitis C in the past ten years; this is a relatively big breakthrough in the field of hepatitis C treatment.

八氢环戊烷[C]吡咯(或其盐)是一种在药物合成中非常有用的医药中间体。它不仅是合成特拉匹韦(Telaprevir)的关键中间体,而且还是糖尿病药物格列齐特(gliclazide)的合成中间体。因此,对于它的大规模工业化生产,具有非常重要的市场价值。八氢环戊烷[C]吡咯为以下结构式(I):Octahydrocyclopentane[C]pyrrole (or its salt) is a very useful pharmaceutical intermediate in drug synthesis. It is not only a key intermediate for the synthesis of telaprevir, but also a synthetic intermediate for the diabetes drug gliclazide. Therefore, for its large-scale industrial production, it has very important market value. Octahydrocyclopentane [C] pyrrole is the following structural formula (I):

八氢环戊烷[C]吡咯的制备方法很早就有文献报道:R.Griot于1959年在Helv.Chim.Acta.,1959,67-72杂志上首次提出了一条直接的合成方法;Griot采用LiAlH4在四氢呋喃溶液中还原环戊酰亚胺(II),以51%收率得到目标化合物八氢环戊烷[C]吡咯(I)。The preparation method of octahydrocyclopentane [C] pyrrole has been reported in the literature for a long time: R.Griot first proposed a direct synthetic method in Helv.Chim.Acta., 1959,67-72 magazine in 1959; Griot The target compound octahydrocyclopentane[C]pyrrole (I) was obtained by reducing cyclopentanimide (II) in tetrahydrofuran solution with LiAlH 4 in 51% yield.

WO2009/55467报道了另一条合成方法:N-苄基环戊酰亚胺先经LiAlH4还原后,再使用10%钯碳(Pd/C)加氢还原以55%的总收率两步得到目标化合物八氢环戊烷[C]吡咯(I)。该方法流程如下:WO2009/55467 reported another synthetic method: N-benzyl cyclopentanimide was first reduced by LiAlH 4 and then hydrogenated with 10% palladium on carbon (Pd/C) to obtain it in two steps with a total yield of 55%. The target compound octahydrocyclopentane[C]pyrrole (I). The method flow is as follows:

在对八氢环戊烷[C]吡咯的药物中间体的工业化研发中,发明人发现以上两种方法一方面得到最终产品的收率都不高,低于55%;此外还均需要使用大量的氢化铝锂(LiAlH4),而LiAlH4是一种遇水非常敏感的化学试剂,实验室在应用时,因为使用量小,危险度还能够容忍;然而在工业化生产中,由于使用量大,其危险性非常大,在还原反应过程中以及后处理过量的还原剂LiAlH4时会剧烈放热,在局部热不均匀的情况下,非常容易发生爆炸等安全事故。一般而言,化学工业化生产中,应该避免使用如LiAlH4这样的遇水非常敏感的化学试剂。In the industrial research and development of the pharmaceutical intermediates of octahydrocyclopentane [C] pyrrole, the inventor found that the yield of the final product obtained by the above two methods on the one hand is not high, lower than 55%; Lithium aluminum hydride (LiAlH 4 ), and LiAlH 4 is a chemical reagent that is very sensitive to water. In laboratory applications, because the amount of use is small, the risk can be tolerated; however, in industrial production, due to the large amount of use , its danger is very high, during the reduction reaction process and after treatment of excess reducing agent LiAlH 4 will violently exothermic, in the case of local heat inhomogeneity, it is very easy to cause safety accidents such as explosion. Generally speaking, chemical reagents that are very sensitive to water such as LiAlH 4 should be avoided in chemical industrial production.

迄今为止,还没有报道八氢环戊烷[C]吡咯的工业化生产方法,迫切需要找到一种安全且高收率的有效工业量化生产方法。So far, no industrial production method of octahydrocyclopentane[C]pyrrole has been reported, and it is urgent to find a safe and effective industrial quantitative production method with high yield.

发明内容Contents of the invention

本发明的目的是提供一种符合工业化生产的八氢环戊烷[C]吡咯(I)的制备方法。The object of the present invention is to provide a kind of preparation method of octahydrocyclopentane [C] pyrrole (I) that is suitable for industrialized production.

为实现上述目的,本发明在深入研究后,设计了制备八氢环戊烷[C]吡咯新的不同于现有技术的方法,即由环戊酰亚胺(II)在适当还原剂及适当促进剂作用下通过“一步法”直接还原得到目标化合物八氢环戊烷[C]吡咯(I)。In order to achieve the above object, after in-depth research, the present invention has designed a new method different from the prior art for preparing octahydrocyclopentane [C] pyrrole, that is, by cyclopentanimide (II) in a suitable reducing agent and a suitable The target compound octahydrocyclopentane[C]pyrrole (I) was obtained by direct reduction under the action of a promoter in a "one-step method".

具体地说,本发明提供的八氢环戊烷[C]吡咯(I)的制备方法,包括将反应底物环戊酰亚胺(II)在硼还原剂以及路易斯酸促进剂作用下,在适当溶剂中,在适当温度下反应,得到目标化合物八氢环戊烷[C]吡咯(I)。Specifically, the preparation method of octahydrocyclopentane [C] pyrrole (I) provided by the present invention comprises the reaction substrate cyclopentanimide (II) under the action of a boron reducing agent and a Lewis acid promoter, in In a suitable solvent, react at a suitable temperature to obtain the target compound octahydrocyclopentane[C]pyrrole (I).

一种实施方式中,所述适当还原剂选自硼氢化钠或硼氢化钾;优选硼氢化钠。In one embodiment, the suitable reducing agent is selected from sodium borohydride or potassium borohydride; preferably sodium borohydride.

一种实施方式中,所述路易斯酸促进剂选自氯化锌、氯化钙、氯化铁、氯化亚铁、氯化镁等;更优选地,所述路易斯酸促进剂为氯化锌。In one embodiment, the Lewis acid accelerator is selected from zinc chloride, calcium chloride, ferric chloride, ferrous chloride, magnesium chloride, etc.; more preferably, the Lewis acid accelerator is zinc chloride.

一种实施方式中,所述适当溶剂为惰性溶剂;所述惰性溶剂选自四氢呋喃、乙腈、1,4-二氧六环、甲苯、二甲苯、苯、乙二醇二甲醚、乙二醇单甲醚、N,N-二甲基甲酰胺、二甲亚砜、氯仿单一溶剂或其中两种或两种以上的混合溶剂。优选地,溶剂为四氢呋喃或甲苯,或两者的混合溶剂。In one embodiment, the appropriate solvent is an inert solvent; the inert solvent is selected from tetrahydrofuran, acetonitrile, 1,4-dioxane, toluene, xylene, benzene, ethylene glycol dimethyl ether, ethylene glycol Monomethyl ether, N,N-dimethylformamide, dimethyl sulfoxide, chloroform as a single solvent or a mixed solvent of two or more of them. Preferably, the solvent is tetrahydrofuran or toluene, or a mixed solvent of the two.

一种实施方式中,反应使用单一溶剂,反应温度为所用溶剂的回流温度。In one embodiment, the reaction uses a single solvent, and the reaction temperature is the reflux temperature of the solvent used.

一种实施方式中,反应使用混合溶剂,反应温度为所用各溶剂的沸点之间的任意温度或是该混合溶剂的共沸温度。In one embodiment, a mixed solvent is used for the reaction, and the reaction temperature is any temperature between the boiling points of the solvents used or the azeotropic temperature of the mixed solvent.

一种实施方式中,所述还原剂与反应底物(II)的摩尔比为1:1至10:1;优选1.1:1至5:1。In one embodiment, the molar ratio of the reducing agent to the reaction substrate (II) is 1:1 to 10:1; preferably 1.1:1 to 5:1.

一种实施方式中,所述促进剂与反应底物(II)的摩尔比为0.5:1至10:1;优选1.1:1至5:1。In one embodiment, the molar ratio of the accelerator to the reaction substrate (II) is 0.5:1 to 10:1; preferably 1.1:1 to 5:1.

与目前已公开的技术相比,本发明的制备新方法通过还原环戊酰亚胺化合物(II),一步法制备八氢环戊烷[C]吡咯(I),优点在于,一方面采用了价格便宜,而且反应温和、操作安全的还原试剂,另一方面通过适当的路易斯酸提升了还原试剂的反应活性,产品收率较高且纯度也高(>97%)。因此该新方法采用的试剂安全、反应条件温和、产物收率高;能很好地符合工业化生产。Compared with the currently disclosed technology, the new preparation method of the present invention prepares octahydrocyclopentane [C] pyrrole (I) in one step by reducing the cyclopentanimide compound (II). The advantage is that, on the one hand, it adopts The reducing agent is cheap, mild in reaction, and safe in operation. On the other hand, the reactivity of the reducing agent is improved by an appropriate Lewis acid, and the product yield is high and the purity is also high (>97%). Therefore, the reagents used in the new method are safe, the reaction conditions are mild, and the product yield is high; it can well meet industrial production.

以下实施例仅仅是进一步阐明本发明,并无将本发明局限于该具体实施例的意图。本领域技术人员应该认识到,本发明涵盖了权利要求书范围内所有可能的备选方案、改进方案和等效方案。The following examples are only to further illustrate the present invention, and are not intended to limit the present invention to the specific examples. Those skilled in the art will realize that the invention covers all possible alternatives, modifications and equivalents within the scope of the claims.

实施例Example

原料及试剂:Raw materials and reagents:

环戊酰亚胺(II)(自制,按照现有文献由1,2-环戊二甲酸与尿脱水缩合而成);Cyclopentanimide (II) (self-made, formed by dehydration and condensation of 1,2-cyclopentadicarboxylic acid and urine according to existing literature);

硼氢化钠、硼氢化钾、氯化锌、氯化铁及其它使用的溶剂及试剂均为国药集团化学试剂有限公司提供。Sodium borohydride, potassium borohydride, zinc chloride, ferric chloride and other solvents and reagents used were provided by Sinopharm Chemical Reagent Co., Ltd.

实施例1Example 1

在氮气氛围下,往一装有机械搅拌器的5L的三口瓶中依次加入四氢呋喃(500mL)、甲苯(1.5L)、硼氢化钠(68.40g,2.5eq.)和氯化锌(125.0g,1.3eq.)。所得悬浮物加热至回流。缓慢蒸出四氢呋喃,使温度控制在90±5℃,直至有黑色固体生成。滴加环戊酰亚胺(100g,0.72mol)的四氢呋喃(500mL)溶液,并在此温度下回流过夜。冷却,用稀盐酸中和至pH=2-3,分去有机相,水相用乙酸乙酯(1L x3)萃取三次,分去有机相。带酸性的水层用碳酸钠饱和溶液中和至pH=8-9后,用乙酸乙酯(1L x3)提取。合并的有机相用硫酸镁干燥。过滤后,滤液减压浓缩。得到白色固体八氢环戊烷[C]吡咯(72.8g,90.9%),HPLC纯度为97%。Under nitrogen atmosphere, tetrahydrofuran (500mL), toluene (1.5L), sodium borohydride (68.40g, 2.5eq.) and zinc chloride (125.0g, 1.3eq.). The resulting suspension was heated to reflux. The tetrahydrofuran was distilled off slowly, and the temperature was controlled at 90±5°C until a black solid was formed. A solution of cyclopentanimide (100 g, 0.72 mol) in tetrahydrofuran (500 mL) was added dropwise and refluxed at this temperature overnight. Cool, neutralize with dilute hydrochloric acid to pH=2-3, separate the organic phase, extract the aqueous phase with ethyl acetate (1L x3) three times, and separate the organic phase. The acidic aqueous layer was neutralized to pH=8-9 with saturated sodium carbonate solution, and then extracted with ethyl acetate (1L x3). The combined organic phases were dried over magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure. Octahydrocyclopentane[C]pyrrole (72.8 g, 90.9%) was obtained as a white solid with an HPLC purity of 97%.

实施例2Example 2

在氮气氛围下,往一装有机械搅拌器的500mL的三口瓶中依次加入四氢呋喃(50mL)、甲苯(150mL)、硼氢化钠(6.84g,2.5eq.)和氯化锌(12.5g,1.3eq.)。所得悬浮物加热至回流。缓慢蒸出四氢呋喃,使温度控制在90±5℃,直至有黑色固体生成。滴加环戊酰亚胺(10g,72mmol)的四氢呋喃(50mL)溶液,并在此温度下回流过夜。冷却,用稀盐酸中和至pH=2-3,分去有机相,水相用乙酸乙酯(100mL x3)萃取三次,分去有机相。带酸性的水层用碳酸钠饱和溶液中和至pH=8-9后,用乙酸乙酯(100mL x3)提取。合并的有机相用硫酸镁干燥。过滤后,滤液减压浓缩。得到白色固体八氢环戊烷[C]吡咯(7.35g,91.8%),HPLC纯度为97%。Under nitrogen atmosphere, tetrahydrofuran (50mL), toluene (150mL), sodium borohydride (6.84g, 2.5eq.) and zinc chloride (12.5g, 1.3 eq.). The resulting suspension was heated to reflux. The tetrahydrofuran was distilled off slowly, and the temperature was controlled at 90±5°C until a black solid was formed. A solution of cyclopentanimide (10 g, 72 mmol) in tetrahydrofuran (50 mL) was added dropwise and refluxed at this temperature overnight. Cool, neutralize with dilute hydrochloric acid to pH=2-3, separate the organic phase, extract the aqueous phase with ethyl acetate (100mL x 3) three times, and separate the organic phase. The acidic aqueous layer was neutralized to pH=8-9 with saturated sodium carbonate solution, and then extracted with ethyl acetate (100mL x3). The combined organic phases were dried over magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure. Octahydrocyclopentane[C]pyrrole (7.35 g, 91.8%) was obtained as a white solid with an HPLC purity of 97%.

实施例3Example 3

在氮气氛围下,往一装有机械搅拌器的500mL的三口瓶中依次加入四氢呋喃(50mL)、甲苯(150mL)、硼氢化钾(9.76g,2.5eq.)和氯化锌(14.4g,1.5eq.)。所得悬浮物加热至回流。缓慢蒸出四氢呋喃,使温度控制在90±5℃,直至有黑色固体生成。滴加环戊酰亚胺(10g,72mmol)的四氢呋喃(50mL)溶液,并在此温度下回流过夜。冷却,用稀盐酸中和至pH=2-3,分去有机相,水相用乙酸乙酯(100mL x3)萃取三次,分去有机相。带酸性的水层用碳酸钠饱和溶液中和至pH=8-9后,用乙酸乙酯(100mL x3)提取。合并的有机相用硫酸镁干燥。过滤后,滤液减压浓缩。得到白色固体八氢环戊烷[C]吡咯(7.33g,91.6%),HPLC纯度为97%。Under nitrogen atmosphere, tetrahydrofuran (50mL), toluene (150mL), potassium borohydride (9.76g, 2.5eq.) and zinc chloride (14.4g, 1.5 eq.). The resulting suspension was heated to reflux. The tetrahydrofuran was distilled off slowly, and the temperature was controlled at 90±5°C until a black solid was formed. A solution of cyclopentanimide (10 g, 72 mmol) in tetrahydrofuran (50 mL) was added dropwise and refluxed at this temperature overnight. Cool, neutralize with dilute hydrochloric acid to pH=2-3, separate the organic phase, extract the aqueous phase with ethyl acetate (100mL x 3) three times, and separate the organic phase. The acidic aqueous layer was neutralized to pH=8-9 with saturated sodium carbonate solution, and then extracted with ethyl acetate (100mL x3). The combined organic phases were dried over magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure. Octahydrocyclopentane[C]pyrrole (7.33 g, 91.6%) was obtained as a white solid with an HPLC purity of 97%.

实施例4Example 4

在氮气氛围下,往一装有机械搅拌器的250mL的三口瓶中依次加入乙腈(25mL)、二甲苯(75mL)、硼氢化钠(4.93g,3.0eq.)和氯化铁(11.5g,2.0eq.)。所得悬浮物加热至90±5。缓慢蒸出四氢呋喃,使温度控制在90±5℃,直至有黑色固体生成。滴加环戊酰亚胺(5g,36mmol)的四氢呋喃(50mL)溶液,并在此温度下过夜。冷却,用稀盐酸中和至pH=2-3,分去有机相,水相用乙酸乙酯(100mL x3)萃取三次,分去有机相。带酸性的水层用碳酸钠饱和溶液中和至pH=8-9后,用乙酸乙酯(100mL x3)提取。合并的有机相用硫酸镁干燥。过滤后,滤液减压浓缩。得到白色固体八氢环戊烷[C]吡咯(3.26g,81.4%),HPLC纯度为95%。Under nitrogen atmosphere, acetonitrile (25mL), xylene (75mL), sodium borohydride (4.93g, 3.0eq.) and ferric chloride (11.5g, 2.0eq.). The resulting suspension was heated to 90±5. The tetrahydrofuran was distilled off slowly, and the temperature was controlled at 90±5°C until a black solid was formed. A solution of cyclopentimide (5 g, 36 mmol) in tetrahydrofuran (50 mL) was added dropwise and left at this temperature overnight. Cool, neutralize with dilute hydrochloric acid to pH=2-3, separate the organic phase, extract the aqueous phase with ethyl acetate (100mL x 3) three times, and separate the organic phase. The acidic aqueous layer was neutralized to pH=8-9 with saturated sodium carbonate solution, and then extracted with ethyl acetate (100mL x3). The combined organic phases were dried over magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure. Octahydrocyclopentane[C]pyrrole (3.26 g, 81.4%) was obtained as a white solid with 95% purity by HPLC.

实施例5Example 5

在氮气氛围下,往一装有机械搅拌器的250mL的三口瓶中依次加入四氢呋喃(25mL)、二甲苯(75mL)、硼氢化钾(11.22g,5.0eq.)和氯化锌(19.32g,4.0eq.)。所得悬浮物加热至90±5℃。缓慢蒸出四氢呋喃,使温度控制在90±5℃,直至有黑色固体生成。滴加环戊酰亚胺(5g,36mmol)的四氢呋喃(50mL)溶液,并在此温度下过夜。冷却,用稀盐酸中和至pH=2-3,分去有机相,水相用乙酸乙酯(50mL x3)萃取三次,分去有机相。带酸性的水层用碳酸钠饱和溶液中和至pH=8-9后,用乙酸乙酯(50mL x3)提取。合并的有机相用硫酸镁干燥。过滤后,滤液减压浓缩。得到白色固体八氢环戊烷[C]吡咯(3.65g,91.2%),HPLC纯度为96%。Under nitrogen atmosphere, tetrahydrofuran (25mL), xylene (75mL), potassium borohydride (11.22g, 5.0eq.) and zinc chloride (19.32g, 4.0eq.). The resulting suspension was heated to 90±5°C. The tetrahydrofuran was distilled off slowly, and the temperature was controlled at 90±5°C until a black solid was formed. A solution of cyclopentimide (5 g, 36 mmol) in tetrahydrofuran (50 mL) was added dropwise and left at this temperature overnight. Cool, neutralize with dilute hydrochloric acid to pH=2-3, separate the organic phase, extract the aqueous phase with ethyl acetate (50mL x3) three times, and separate the organic phase. The acidic aqueous layer was neutralized to pH=8-9 with saturated sodium carbonate solution, and then extracted with ethyl acetate (50mL x3). The combined organic phases were dried over magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure. Octahydrocyclopentane[C]pyrrole (3.65 g, 91.2%) was obtained as a white solid with an HPLC purity of 96%.

Claims (6)

1. the preparation technology of octahydro pentamethylene [C] pyrroles I, it is characterized in that, by reaction substrate ring valeryl imines II under boron reductive agent, lewis promoters effect, react in appropriate solvent, under proper temperature, obtain target compound octahydro pentamethylene [C] pyrroles I; Chemical reaction is shown in following formula:
Described boron reductive agent is sodium borohydride or POTASSIUM BOROHYDRIDE, and described lewis promoters is zinc chloride,
Described appropriate solvent is selected from two or more the mixed solvent in tetrahydrofuran (THF), toluene, dimethylbenzene,
Described proper temperature is arbitrary temp between the boiling point of each solvent used or the azeotropic temperature of this mixed solvent.
2. preparation technology as claimed in claim 1, it is characterized in that, described appropriate solvent is selected from the mixed solvent of tetrahydrofuran (THF) and toluene.
3. preparation technology as claimed in claim 1, it is characterized in that, the mol ratio of described reductive agent and reaction substrate ring valeryl imines II is 1:1 to 10:1.
4. preparation technology as claimed in claim 3, it is characterized in that, the mol ratio of described reductive agent and reaction substrate ring valeryl imines II is 1.1:1 to 5:1.
5. preparation technology as claimed in claim 1, it is characterized in that, the mol ratio of described promotor and reaction substrate ring valeryl imines II is 0.5:1 to 10:1.
6. preparation technology as claimed in claim 5, it is characterized in that, the mol ratio of described promotor and reaction substrate ring valeryl imines II is 1:1 to 5:1.
CN201310627653.8A 2013-11-28 2013-11-28 The preparation method of octahydro pentamethylene [C] pyrroles Expired - Fee Related CN103601666B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310627653.8A CN103601666B (en) 2013-11-28 2013-11-28 The preparation method of octahydro pentamethylene [C] pyrroles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310627653.8A CN103601666B (en) 2013-11-28 2013-11-28 The preparation method of octahydro pentamethylene [C] pyrroles

Publications (2)

Publication Number Publication Date
CN103601666A CN103601666A (en) 2014-02-26
CN103601666B true CN103601666B (en) 2015-09-02

Family

ID=50119950

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310627653.8A Expired - Fee Related CN103601666B (en) 2013-11-28 2013-11-28 The preparation method of octahydro pentamethylene [C] pyrroles

Country Status (1)

Country Link
CN (1) CN103601666B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109206357A (en) * 2017-07-04 2019-01-15 浙江九洲药业股份有限公司 A kind of general formula compound and its preparation method and application of gliclazide intermediate
CN109438325A (en) * 2018-12-05 2019-03-08 兰州大学 A kind of method of ring valeryl imines catalytic hydrogenation synthesis octahydro pentamethylene [C] pyrroles
CN116283719B (en) * 2023-03-28 2023-09-08 安徽金鼎医药股份有限公司 Preparation process and preparation system of gliclazide intermediate amino heterocyclic hydrochloride
CN117510394A (en) * 2023-11-08 2024-02-06 内蒙古源宏精细化工有限公司 Preparation method of N-amino-3-azabicyclo [3, 0] octane hydrochloride

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101235011A (en) * 2008-03-11 2008-08-06 浙江大学 N-amino-1,2-cyclopentane dicarboximide and its preparation method
CN101381338A (en) * 2007-09-03 2009-03-11 上海医药工业研究院 The preparation method of cis-perhydroisoindole
WO2009140279A2 (en) * 2008-05-12 2009-11-19 Concert Pharmaceuticals, Inc. Sulfonyl urea compounds
CN102816102A (en) * 2011-06-08 2012-12-12 瑟维尔实验室 Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it
CN102924362A (en) * 2012-10-26 2013-02-13 浙江工业大学 Preparation method of hexahydro-2-cyclopentyl-pyrryl amine hydrochloride
WO2013050301A1 (en) * 2011-10-03 2013-04-11 Syngenta Participations Ag Enantionselective processes to insecticidal 3-aryl-3-trifluoromethyl-substituted pyrrolidines
TW201341358A (en) * 2012-01-06 2013-10-16 Lonza Ag Method for preparation of octahydrocyclopenta[c] pyrrole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004131399A (en) * 2002-10-08 2004-04-30 Ihara Chem Ind Co Ltd Method for producing cis-hexahydroisoindoline

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101381338A (en) * 2007-09-03 2009-03-11 上海医药工业研究院 The preparation method of cis-perhydroisoindole
CN101235011A (en) * 2008-03-11 2008-08-06 浙江大学 N-amino-1,2-cyclopentane dicarboximide and its preparation method
WO2009140279A2 (en) * 2008-05-12 2009-11-19 Concert Pharmaceuticals, Inc. Sulfonyl urea compounds
CN102816102A (en) * 2011-06-08 2012-12-12 瑟维尔实验室 Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it
WO2013050301A1 (en) * 2011-10-03 2013-04-11 Syngenta Participations Ag Enantionselective processes to insecticidal 3-aryl-3-trifluoromethyl-substituted pyrrolidines
TW201341358A (en) * 2012-01-06 2013-10-16 Lonza Ag Method for preparation of octahydrocyclopenta[c] pyrrole
CN102924362A (en) * 2012-10-26 2013-02-13 浙江工业大学 Preparation method of hexahydro-2-cyclopentyl-pyrryl amine hydrochloride

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A practical and efficient procedure for reduction of carboxylic acids and their derivatives: use of KBH4–MgCl2;You-Chun Qiu,等;《Tetrahedron Letters》;20070904;第48卷(第43期);第7595-7598页 *
硼氢化钠在有机合成中的新应用;车荣睿;《化学试剂》;19861231;第8卷(第02期);第94-98页 *

Also Published As

Publication number Publication date
CN103601666A (en) 2014-02-26

Similar Documents

Publication Publication Date Title
CN103601666B (en) The preparation method of octahydro pentamethylene [C] pyrroles
CN103113240B (en) Process for directly synthesizing p-aminophenol through hydrogenation of nitrobenzene
CN102659919A (en) Synthetic method of bortezomib
CN103467341B (en) Preparation method for 2-cyano-4'-methylbiphenyl
CN105541714A (en) Preparation methods of papaverine and papaverine hydrochloride
CN104086392A (en) Catalytic synthesis method for biphenylacetic acid
CN106892826B (en) A kind of preparation method and application of amine and imine nitrogen methylation
CN103804234B (en) The synthetic method of Alpha-Methyl-(3,4-Dimethoxyphenyl)-alpha-amino group propionitrile
CN105218502B (en) asymmetric synthesis method of chiral chroman compound
CN105859761A (en) Synthesis method of aromatic borate compounds
CN103739545B (en) A kind of convenient preparation method of vitamin B6
CN106117204B (en) The preparation method of the carboxylic acid of Lei Dipawei intermediates (1R, 3S, 4S) 2 Boc 2 azabicyclo [2.2.1] pentane 3
CN103113254A (en) Technology for directly synthesizing acetaminophen from nitrobenzene
CN104788482B (en) A method for preparing 2-aminopyrimidine-5-boronic acid pinacol ester
CN101812020A (en) Synthesis method of tetra-substituted imidazole medicament molecule and analogs thereof
CN101538211A (en) Method for preparing m-aminophenol by catalytic hydrolysis of m-phenylenediamine
CN102617475A (en) Method for decarboxylation of N-methyl-3-alkyl-4 -nitropyrazole formate
CN118184540B (en) Preparation method of 2-fluoro-5-formylbenzonitrile
CN102796062B (en) Method for preparing flumorph
CN104788370B (en) A kind of method that configuration controllably synthesizes 2 (4 nitro) bytyry N-oxide compounds
CN105315288B (en) It is a kind of to prepare nafoxidine and the method for pyrazine and isoindole derivatives
CN110511147B (en) A kind of reduction method of nitroalkene
CN102757376A (en) Preparation method of b-heterocyclic ketone compound
CN106749041A (en) A kind of method of synthesizing cytimidine
CN106977488B (en) A kind of preparation method of 6H- benzo [C] chromene and its derivative

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150902

Termination date: 20201128